IO Biotech, Inc. (IOBT)
NASDAQ: IOBT · Real-Time Price · USD
0.2901
-0.0262 (-8.28%)
Jan 30, 2026, 4:00 PM EST - Market closed

IO Biotech Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Jan '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
216112466184-
Market Cap Growth
-59.89%-51.06%86.88%-64.06%--
Enterprise Value
8-18-39-82268-
Last Close Price
0.290.921.882.306.40-
PB Ratio
22.191.290.930.480.87-
P/TBV Ratio
22.911.290.930.480.87-
Debt / Equity Ratio
19.890.040.020.02--
Quick Ratio
1.733.149.1813.5020.731.61
Current Ratio
2.013.339.3713.8821.521.85
Return on Equity (ROE)
-240.48%-106.00%-63.29%-40.74%-63.28%-2127.56%
Return on Assets (ROA)
-88.58%-54.47%-37.78%-23.87%-22.61%-84.11%
Return on Capital Employed (ROCE)
-425.30%-197.40%-67.70%-50.60%-19.50%-389.70%
Earnings Yield
-423.28%-157.55%-69.50%-107.82%-36.81%-
FCF Yield
-388.38%-135.94%-58.18%-91.16%-22.12%-
Buyback Yield / Dilution
-0.31%-51.31%-51.10%-564.62%-2346.74%-
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q